Zevra Therapeutics Inc. (ZVRA) Insider Trading
- $384,610.58
- $674,175.78
- Feb. 13, 2025
- R. Laduane Clifton
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Feb. 13, 2025 | EVP | 10,500 | $7.86 | Sell | $82,530.00 | |
| Feb. 13, 2025 | CEO | 61,273 | $7.86 | Sell | $481,605.78 | |
| Feb. 13, 2025 | CFO | 11,000 | $7.86 | Sell | $86,460.00 | |
| Feb. 13, 2025 | SVP | 3,000 | $7.86 | Sell | $23,580.00 | |
| Oct. 11, 2024 | Director | 500 | $7.92 | Buy | $3,960.00 | |
| July 17, 2024 | CFO | 2,000 | $6.77 | Buy | $13,540.00 | |
| July 16, 2024 | Director | 10,000 | $6.81 | Buy | $68,100.00 | |
| July 12, 2024 | Director | 10,000 | $5.87 | Buy | $58,700.00 | |
| Sept. 6, 2023 | CFO | 1,000 | $4.96 | Buy | $4,960.00 | |
| Sept. 5, 2023 | EVP | 500 | $5.13 | Buy | $2,565.00 | |
| Sept. 5, 2023 | Director | 10,000 | $5.13 | Buy | $51,300.00 | |
| June 23, 2023 | Director | 275 | $5.95 | Buy | $1,636.25 | |
| June 9, 2023 | Director | 325 | $5.52 | Buy | $1,794.00 | |
| May 30, 2023 | Director | 400 | $5.11 | Buy | $2,044.00 | |
| May 18, 2023 | Director | 10,000 | $5.04 | Buy | $50,400.00 | |
| May 18, 2023 | CFO | 2,740 | $4.95 | Buy | $13,563.00 | |
| March 17, 2023 | Director | 519 | $4.82 | Buy | $2,501.58 | |
| March 14, 2023 | EVP | 2,000 | $4.61 | Buy | $9,220.00 | |
| March 10, 2023 | SVP | 1,200 | $4.14 | Buy | $4,968.00 | |
| March 10, 2023 | CFO | 1,725 | $4.15 | Buy | $7,158.75 | |
| March 9, 2023 | CEO | 10,000 | $4.20 | Buy | $42,000.00 | |
| March 9, 2023 | Director | 11,000 | $4.20 | Buy | $46,200.00 |
Insiders are both buying and selling Zevra Therapeutics Inc. stock.
The insider traders at Zevra Therapeutics Inc. are: R. Laduane Clifton, Corey Michael Watton, John B Bode, Joshua Schafer, Timothy J Sangiovanni, Richard W Pascoe, Neil F Mcfarlane, Tamara A Seymour, Thomas Anderson, and Matthew R Plooster
The most active insider trader at Zevra Therapeutics Inc. is R. Laduane Clifton with 5 trades.
Neil F Mcfarlane has sold the most Zevra Therapeutics Inc. stock with a total value of $963,211.56.
John B Bode has bought the most Zevra Therapeutics Inc. stock with a total value of $219,100.00.
The most recent insider trade for Zevra Therapeutics Inc. was on Feb. 13, 2025.
The single biggest insider buy for Zevra Therapeutics Inc. was from Thomas Anderson with a total value of $68,100.00 on July 16, 2024.
The single biggest insider sell for Zevra Therapeutics Inc. was from Neil F Mcfarlane with a total value of $481,605.78 on Feb. 13, 2025.